Gabrielle Ene

University Health Network

Papers

1

Total Citations

224

H-Index

1

About

Dr. Gabrielle Ene is a leading gynecologic oncologist whose research has fundamentally reshaped surgical staging for endometrial cancer. Her most influential work, a landmark 2020 study with over 220 citations, rigorously evaluated whether sentinel lymph node biopsy (SLNB) can safely replace full lymphadenectomy for intermediate- and high-grade endometrial cancer. By examining the diagnostic accuracy and morbidity of SLNB using indocyanine green, Dr. Ene provided critical evidence that this less invasive approach offers comparable staging information while significantly reducing surgical complications. This contribution has directly influenced clinical guidelines and practice, sparing countless patients the morbidity of extensive lymph node dissection. Beyond this pivotal study, her research portfolio focuses on optimizing surgical techniques and improving oncologic outcomes for women with gynecologic malignancies. Dr. Ene’s work exemplifies how high-quality surgical trials can translate into meaningful changes in patient care, establishing her as a key voice in the movement toward precision, minimally invasive staging in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
224
Total Citations
224
Avg Citations/Paper
🏆 Most Cited Paper
Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
224 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University Health Network

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago